Theriva Biologics Files 8-K for Material Agreement
Ticker: TOVX · Form: 8-K · Filed: May 8, 2025 · CIK: 894158
| Field | Detail |
|---|---|
| Company | Theriva Biologics, Inc. (TOVX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
TL;DR
Theriva Biologics just signed a big deal, filing an 8-K on it. Check the details.
AI Summary
On May 7, 2025, Theriva Biologics, Inc. entered into a material definitive agreement. The company, formerly known as Synthetic Biologics, Inc., filed an 8-K report detailing this event. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a significant new development for Theriva Biologics, potentially impacting its business operations and future strategy.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, requiring further analysis of the agreement's terms and implications.
Key Players & Entities
- Theriva Biologics, Inc. (company) — Registrant
- May 7, 2025 (date) — Date of earliest event reported
- Synthetic Biologics, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Theriva Biologics?
The filing states that Theriva Biologics, Inc. entered into a material definitive agreement on May 7, 2025, but the specific details of this agreement are not provided in the provided text.
What was Theriva Biologics, Inc. formerly known as?
Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc., with a date of name change on March 5, 2012.
When was the report filed?
The report was filed on May 8, 2025.
In which state is Theriva Biologics, Inc. incorporated?
Theriva Biologics, Inc. is incorporated in Nevada.
What is the IRS Employer Identification Number for Theriva Biologics, Inc.?
The IRS Employer Identification Number for Theriva Biologics, Inc. is 13-3808303.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Theriva Biologics, Inc. (TOVX).